SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 56 filers reported holding SAVARA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,525,416 | -21.8% | 3,313,602 | -33.5% | 47.59% | +2.9% |
| Q2 2023 | $16,026,005 | +19.2% | 4,980,804 | -27.8% | 46.25% | +36.1% |
| Q1 2023 | $13,448,274 | +25.8% | 6,896,551 | 0.0% | 33.97% | +24.4% |
| Q4 2022 | $10,689,654 | -0.0% | 6,896,551 | 0.0% | 27.30% | +35.8% |
| Q3 2022 | $10,690,000 | +2.0% | 6,896,551 | 0.0% | 20.10% | +42.7% |
| Q2 2022 | $10,483,000 | +16.0% | 6,896,551 | 0.0% | 14.08% | +25.4% |
| Q1 2022 | $9,034,000 | +5.3% | 6,896,551 | -0.3% | 11.23% | +60.2% |
| Q4 2021 | $8,577,000 | -9.9% | 6,916,551 | +0.3% | 7.01% | -9.1% |
| Q3 2021 | $9,517,000 | -5.9% | 6,896,551 | +15.9% | 7.71% | +11.3% |
| Q2 2021 | $10,117,000 | -15.4% | 5,951,015 | +3.5% | 6.93% | -10.8% |
| Q1 2021 | $11,965,000 | – | 5,752,215 | – | 7.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 3,313,602 | $12,525,416 | 47.59% |
| NEA Management Company, LLC | 24,471,264 | $92,501,378 | 7.14% |
| Bain Capital Life Sciences Investors, LLC | 14,232,751 | $53,799,799 | 6.02% |
| TCG Crossover Management, LLC | 10,000,000 | $37,800,000 | 5.57% |
| VR Adviser, LLC | 7,184,865 | $27,158,790 | 2.86% |
| Affinity Asset Advisors, LLC | 1,150,000 | $4,347,000 | 1.22% |
| Sio Capital Management, LLC | 896,250 | $3,387,825 | 1.05% |
| Frazier Life Sciences Management, L.P. | 4,000,000 | $15,120,000 | 1.00% |
| Vivo Capital, LLC | 1,913,349 | $7,232,459 | 0.79% |
| Nantahala Capital Management | 1,039,364 | $3,928,796 | 0.34% |